A synthetic biology roadmap for sustainable production of the plant-originated anti-cancer drug paclitaxel.

Paclitaxel, a clinically potent anticancer drug derived from Taxus species, faces persistent challenges in sustainable supply. Synthetic biology presents substantial opportunities for its de novo production, particularly with recent breakthroughs in…

Preview only. Read the full abstract at the source